Detalhe da pesquisa
1.
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.
Blood
; 132(7): 694-706, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29907599
2.
Activation of HIF-1α by δ-Opioid Receptors Induces COX-2 Expression in Breast Cancer Cells and Leads to Paracrine Activation of Vascular Endothelial Cells.
J Pharmacol Exp Ther
; 370(3): 480-489, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31300611
3.
Cdk6 contributes to cytoskeletal stability in erythroid cells.
Haematologica
; 102(6): 995-1005, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28255017
4.
Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3.
Neoplasia
; 23(2): 270-279, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33465556
5.
In-vitro binding analysis of anti-human vascular endothelial growth factor antibodies bevacizumab and aflibercept with canine, feline, and equine vascular endothelial growth factor.
Res Vet Sci
; 124: 233-238, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30933891
6.
In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD-0332991) for treating canine mammary tumours.
Vet Comp Oncol
; 17(4): 507-521, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207004